• Citer

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.

par Demeestere, Isabelle ;Brice, Pauline;Peccatori, Fedro Alessandro;Kentos, Alain ;Dupuis, Jehan;Zachée, Pierre;Casasnovas, Olivier;Van Den Neste, Eric;Dechene, Julie ;De Maertelaer, Viviane ;Bron, Dominique ;Englert, Yvon
Référence Journal of clinical oncology, 34, 22, page (2568-74), Selected for editorial
Publication Publié, 2016-05

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.
Auteur:	Demeestere, Isabelle; Brice, Pauline; Peccatori, Fedro Alessandro; Kentos, Alain; Dupuis, Jehan; Zachée, Pierre; Casasnovas, Olivier; Van Den Neste, Eric; Dechene, Julie; De Maertelaer, Viviane; Bron, Dominique; Englert, Yvon
Informations sur la publication:	Journal of clinical oncology, 34, 22, page (2568-74), Selected for editorial
Statut de publication:	Publié, 2016-05
Sujet CREF:	Hématologie
	Gynécologie
	Cancérologie
MeSH keywords:	Adult
	Female
	Fertility -- drug effects
	Fertility Preservation -- methods
	Gonadotropin-Releasing Hormone -- agonists
	Humans
	Lymphoma -- drug therapy
	Middle Aged
	Norethindrone -- therapeutic use
	Ovary -- drug effects -- physiology
	Primary Ovarian Insufficiency -- prevention & control
	Prospective Studies
	Triptorelin Pamoate -- administration & dosage
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2015.65.8864
	info:pii/JCO.2015.65.8864
	info:scp/84979265954
	info:pmid/27217453